Research by the Oral Health CRC (and its predecessor) has resulted in 14 patent families.
Patent title |
Description |
| Antigenic complex for the diagnosis and treatment of P.gingivalis infection | Relevant to development of vaccines, diagnostics and pharmaceuticals for periodontal disease |
| Stablised calcium phosphate complexes | Improvement to the CPP-ACP complex |
| Dental mineralisation | Improvement to the CPP-ACP complex |
| Ionic complexes | Improvement to the CPP-ACP complex |
| Fluoride composition and methods for dental mineralisation | Improvement to the CPP-ACP complex |
| Porphyromonas gingivalis polypeptides useful in the prevention of periodontal disease | Relevant to the development of vaccines, diagnostics and pharmaceuticals for periodontal disease |
| Immunology treatment for biofilms | Relevant to the development of vaccines, diagnostics and pharmaceuticals for periodontal disease |
| Biofilm treatment | Relevant to the development of vaccines, diagnostics and pharmaceuticals for periodontal disease |
| Prevention, treatment and diagnosis of P.gingivalis infection | Relevant to the development of vaccines, diagnostics and pharmaceuticals for periodontal disease |
| Periodontal disease treatment | Relevant to the development of vaccines, diagnostics and pharmaceuticals for periodontal disease |
| Antibiofilm glycopeptides | Relevant to the treatment or prevention of oral conditions including dental caries, gingivitis, periodontitis and oral mucositis |
| Protease inhibitory peptides | Relevant to the development of vaccines, diagnostics and pharmaceuticals for periodontal disease |
| Treatment or prevention of infection | Relevant to the development of vaccines, diagnostics and pharmaceuticals for periodontal disease |
| Gingipain inhibitory propeptides | Relates to compounds, peptides or peptidomimetics that inhibit, reduce or prevent protease activity and the use of these compounds, peptides or peptidomimetics to treat or prevent a condition. |